Anti-Cd20 Immunotherapy as a Bridge to Tolerance, After Allogeneic Stem Cell Transplantation for Patients With Chronic Lymphocytic Leukaemia: Results of the CLLX4 Trial

British Journal of Haematology - United Kingdom
doi 10.1111/bjh.15181

Related search